From bad to worse: Prognostic factors in pancreatic cancer

被引：2

作者：

Lowy, AM ^{[1
]}

机构：

[1] Univ Cincinnati, Med Ctr, Barrett Canc Ctr, Dept Surg, Cincinnati, OH 45267 USA

来源：

ANNALS OF SURGICAL ONCOLOGY | 2004年 / 11卷 / 02期

关键词：

D O I：

10.1245/ASO.2004.12.930

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：117 / 118

页数：2

相关论文

共 5 条

[1] K-ras mutations in DNA extracted from the plasma of patients with pancreatic carcinoma:: Diagnostic utility and prognostic significance [J].

Castells, A ;

Puig, P ;

Móra, J ;

Boadas, J ;

Boix, L ;

Urgell, E ;

Solé, M ;

Capellà, G ;

Lluis, F ;

Fernández-Cruz, L ;

Navarro, S ;

Farré, A .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (02) :578-584

[2] Long-term survival after curative resection for pancreatic ductal adenocarcinoma - Clinicopathologic analysis of 5-year survivors [J].

Conlon, KC ;

Klimstra, DS ;

Brennan, MF .

ANNALS OF SURGERY, 1996, 223 (03) :273-279

[3] p53 alteration is not an independent prognostic indicator, but affects the efficacy of adjuvant chemotherapy in human pancreatic cancer [J].

Dong, M ;

Nio, Y ;

Yamasawa, K ;

Toga, T ;

Yue, LS ;

Harada, T .

JOURNAL OF SURGICAL ONCOLOGY, 2003, 82 (02) :111-120

[4]

Gansauge S, 1997, CANCER RES, V57, P1634

[5] Increased expression of valosin-containing protein (p97) is associated with lymph node metastasis and prognosis of pancreatic ductal adenocarcinoma [J].

Yamamoto, S ;

Tomita, Y ;

Hoshida, Y ;

Nagano, H ;

Dono, K ;

Umeshita, K ;

Sakon, M ;

Ishikawa, O ;

Ohigashi, H ;

Nakamori, S ;

Monden, M ;

Aozasa, K .

ANNALS OF SURGICAL ONCOLOGY, 2004, 11 (02) :165-172